Publications by authors named "Isabelle Chemin"

Claim this Profile
V
Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The Gambia.
Erwan Vo-Quang, Christophe Rodriguez, Arnaud Ly, Gibril Ndow, Alexandre Soulier, Isabelle Chemin

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and molecular characterization of hepatitis delta virus infection among hepatitis B virus surface antigen positive students and pregnant women in N'djamena, Chad.
Nalda Debsikréo, Maire Dehainsala, Odan Debsikréo, Nafissatou Leye, Gora Lo, Isabelle Chemin

IJID Reg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple burden of hepatitis B, hepatitis Delta viruses, and to pregnant women.
Aude Sandrine Andeme Eyi, Opheelia Makoyo Komba, Claire Chambellant, Ismaël Pierrick Mikelet Boussoukou, Lydie Moukambi, Isabelle Chemin

IJID Reg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study.
Gibril Ndow, Yusuke Shimakawa, Damien Leith, Sulayman Bah, Rohey Bangura, Isabelle Chemin

Lancet Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Diagnostic Accuracy and Clinical Utility of Hepatitis B Virus (HBV) Nucleic Acid Testing Using the GeneXpert Point-of-Care Test System from Fresh Plasma and Dry Blood Spot Samples in The Gambia.
Amie Ceesay, Sainabou Drammeh, Gibril Ndow, Alpha Omar A Jallow, Haddy Nyang, Isabelle Chemin

Microorganisms· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes.
Fleur Chapus, Guillaume Giraud, Pélagie Huchon, Mélanie Rodà, Xavier Grand, Isabelle Chemin

J Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Hepatitis B Virus (HBV) Infection 2.0.
Isabelle Chemin, Flor Helene Pujol

Microorganisms· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study.
Gibril Ndow, Erwan Vo-Quang, Yusuke Shimakawa, Amie Ceesay, Saydiba Tamba, Isabelle Chemin

Lancet Glob Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populations.
Armando Andres Roca Suarez, Séverine Planel, Xavier Grand, Céline Couturier, Trang Tran, Isabelle Chemin

Front Cell Infect Microbiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B eradication: vaccine as a key player.
Flor Helene Pujol, Rayana Maryse Toyé, Carmen Luisa Loureiro, Rossana Celeste Jaspe, Isabelle Chemin

Am J Transl Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes.
Rayana Maryse Toyé, Carmen Luisa Loureiro, Rossana Celeste Jaspe, Fabien Zoulim, Flor Helene Pujol, Isabelle Chemin

Microorganisms· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline.
Caroline Charre, Hadrien Regue, Paul Dény, Laurence Josset, Isabelle Chemin

J Med Virol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Isabelle Chemin

J Glob Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.
Amina Sow, Maud Lemoine, Papa Souleymane Toure, Madoky Diop, Gora Lo, Isabelle Chemin

JHEP Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries.
Amie Ceesay, Khaled Bouherrou, Boun Kim Tan, Maud Lemoine, Gibril Ndow, Isabelle Chemin

Microorganisms· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa.
Gibril Ndow, Amie Cessay, Damien Cohen, Yusuke Shimakawa, Mindy L Gore, Isabelle Chemin

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy.
Alexia Paturel, Janet Hall, Isabelle Chemin

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa.
Amie Ceesay, Maud Lemoine, Damien Cohen, Isabelle Chemin, Gibril Ndow

Expert Rev Mol Diagn· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue: "Updates on HBV Infection".
Isabelle Chemin, Flor Helene Pujol

Microorganisms· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?
Laetitia Gerossier, Anaëlle Dubois, Alexia Paturel, Nadim Fares, Damien Cohen, Isabelle Chemin

Clin Res Hepatol Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B.
Gerrit Post, Jess Howell, Amina Sow, Gibril Ndow, Isabelle Chemin

J Viral Hepat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cas9-targeted nanopore sequencing reveals epigenetic heterogeneity after assembly of native full-length hepatitis B virus genomes.
Chloe Goldsmith, Damien Cohen, Anaëlle Dubois, Maria Guadalupe Martinez, Kilian Petitjean, Isabelle Chemin

Microb Genom· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Rayana Maryse Toyé, Gora Lô, Halimatou Diop-Ndiaye, Abdoul Magib Cissé, Anna Julienne Selbé Ndiaye, Isabelle Chemin

Clin Res Hepatol Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Virus Genotype Study in West Africa Reveals an Expanding Clade of Subgenotype A4.
Rayana Maryse Toyé, Damien Cohen, Flor Helene Pujol, Amina Sow-Sall, Gora Lô, Isabelle Chemin

Microorganisms· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.
Damien Cohen, Sumantra Ghosh, Yusuke Shimakawa, Njie Ramou, Pierre Simon Garcia, Isabelle Chemin

JHEP Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis